SAVE MONEY ON TRAVEL DEALS

Lead researcher Zheng Cui announced the study at the Understanding Aging conference in Los Angeles. The study, given the go-ahead by the U.S. Food and Drug Administration, will involve treating human cancer patients with white blood cells from healthy young people whose immune systems produce cells with high levels of cancer-fighting activity.

The basis of the study is the scientists' discovery, published five years ago, of a cancer-resistant mouse and their subsequent finding that white blood cells from that mouse and its offspring cured advanced cancers in ordinary laboratory mice. They have since identified similar cancer-killing activity in the white blood cells of some healthy humans.

"In mice, we've been able to eradicate even highly aggressive forms of malignancy with extremely large tumors", Cui said in a statement. "Hopefully, we will see the same results in humans. Our laboratory studies indicate that this cancer-fighting ability is even stronger in healthy humans."

 BREAKING STORIES

Home warning system for cardiac patients

African-American COPD links to lung cancer

Pussycat Dolls wow Fashion Rocks

West Nile virus claims 3rd Californian

Jesse Jackson Sr. released from hospital

Failed anxiety drug may fight cancer

Test could lead to better BSE detection

Universal flu vaccine tested on humans

Clues to treat brain cancer discovered

Cigarettes' attraction may not nicotine

Breakfast protein may help in weight loss

Nursing mothers with MRSA can be treated

Sexy Mendes billboard graces Times Square

Intensive care unit can traumatize kids

Coroner: Mysterious deaths were natural

Family fights over woman's life support

Quercetin, found in produce, fights flu

2.4 million smoking-linked cancers 1999/04

FDA approves hepatitis B viral DNA test

Scientists ID Ebola cell-invasion strategy